US HB1683 | 2023-2024 | 118th Congress

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 21 2023 - 25% progression, died in committee
Action: 2023-03-31 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend the Federal Food, Drug, and Cosmetic Act to make certain changes with respect to the approval of abbreviated applications for the approval of new animal drugs, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Generic Animal Drug Advancement Act

Sponsors

Rep. Nancy Mace [R-SC]

History

DateChamberAction
2023-03-31HouseReferred to the Subcommittee on Health.
2023-03-21HouseReferred to the House Committee on Energy and Commerce.
2023-03-21HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback